Recall image placeholder

No image published for this recall

Omnipod® insulin management system - omnipod®

Official notice

1 Jun 2026

Last checked

1 Jun 2026

Critical riskHealth Canada
Watch Insulet

An official Health Canada notice concerns Omnipod® insulin management system - omnipod®. The defect is related to tears on the external (exposed) soft cannula. The defect is consistently located near the bottom housing window, with similar physical appearance and tear orientation across devices. The cannula tear may result in a compromised fluid path due to damage to the cannula, leading to potential reduced or interrupted insulin delivery. If insulin is not delivered properly, user may experience high blood glucose levels due to under-delivery of insulin. In the most severe cases, prolonged and persistent high blood glucose levels can lead to diabetic ketoacidosis (DKA), a serious medical condition that requires prompt medical treatment and can be life-threatening if not treated. To identify the impacted product and lot number, users will be asked to review the notification letter and follow the instructions: Discontinue use of any impacted pod immediately. If the pod the user is currently using, is from an affected lot, it is important that the user immediately changes the pod to resume insulin delivery. When changing the pod, confirm that the new pod is not from an affected lot. Published 2026-06-01.

What to do now

For further details on this recall, please refer to the manufacturer’s website at: https://www.omnipod.com/en-ca/fsn-5-26

Recall number

82140

Official notice

2026-06-01

The hazard

The defect is related to tears on the external (exposed) soft cannula. The defect is consistently located near the bottom housing window, with similar physical appearance and tear orientation across devices. The cannula tear may result in a compromised fluid path due to damage to the cannula, leading to potential reduced or interrupted insulin delivery. If insulin is not delivered properly, user may experience high blood glucose levels due to under-delivery of insulin. In the most severe cases, prolonged and persistent high blood glucose levels can lead to diabetic ketoacidosis (DKA), a serious medical condition that requires prompt medical treatment and can be life-threatening if not treated. To identify the impacted product and lot number, users will be asked to review the notification letter and follow the instructions: Discontinue use of any impacted pod immediately. If the pod the user is currently using, is from an affected lot, it is important that the user immediately changes the pod to resume insulin delivery. When changing the pod, confirm that the new pod is not from an affected lot.

How to check if you're affected

Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.

Lots

L72521, L72516, PH1U01222522, users

Skus

ZXR420, POD-ZXR425, POD-OMNI-I1-6729, POD-BLE-C1-520, POD-BLE-C1-529, POD-OMNI-I1-6720

Other

RA RA-82140

Model Numbers

ZXR420, POD-ZXR425, POD-OMNI-I1-6729, POD-BLE-C1-520, POD-BLE-C1-529, POD-OMNI-I1-6720

Recall Numbers

82140

Checked manually this time?

The app watches your VIN and alerts you automatically next time — no searching, no checking back.

Turn on automatic VIN checks

Affected products

Product 1

Lot or serial number - L72521, Model or catalogue number - ZXR420

Product 2

Lot or serial number - L72516, Model or catalogue number - POD-ZXR425

Product 3

Lot or serial number - PH1U01222522, Model or catalogue number - POD-OMNI-I1-6729

Product 4

Lot or serial number - More than 10 numbers, contact manufacturer., Model or catalogue number - POD-BLE-C1-520

Product 5

Lot or serial number - More than 10 numbers, contact manufacturer., Model or catalogue number - POD-BLE-C1-529

Product 6

Lot or serial number - PH1U01222522, Model or catalogue number - POD-OMNI-I1-6720

Risk / hazard

The defect is related to tears on the external (exposed) soft cannula. The defect is consistently located near the bottom housing window, with similar physical appearance and tear orientation across devices. The cannula tear may result in a compromised fluid path due to damage to the cannula, leading to potential reduced or interrupted insulin delivery. If insulin is not delivered properly, user may experience high blood glucose levels due to under-delivery of insulin. In the most severe cases, prolonged and persistent high blood glucose levels can lead to diabetic ketoacidosis (DKA), a serious medical condition that requires prompt medical treatment and can be life-threatening if not treated. To identify the impacted product and lot number, users will be asked to review the notification letter and follow the instructions: Discontinue use of any impacted pod immediately. If the pod the user is currently using, is from an affected lot, it is important that the user immediately changes the pod to resume insulin delivery. When changing the pod, confirm that the new pod is not from an affected lot.

Where it was sold

The source does not list specific retailers. See the official notice for where affected vehicles were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Brand

Insulet

Manufacturer

Not provided

Phone

Not provided

Brand: Insulet.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

Classification

Type I

App estimate

critical

Recall details

Recall number

82140

Classification

Type I

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
Recall image placeholder

Omnipod dash system

High riskHealth Canada27 Oct 2022
CA
Recall image placeholder

Intramedullary bone saw blade assembly

Medium riskHealth Canada3 Jul 2026
CA
Recall image placeholder

Glidesheath slender® introducer sheath

Medium riskHealth Canada2 Jul 2026
CA
Recall image placeholder

Abiomed introducer kits with impella heart pumps

High riskHealth Canada29 Jun 2026
CA
Recall image placeholder

Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)

Medium riskHealth Canada22 Jun 2026
CA
Recall image placeholder

Cyberknife® treatment delivery system

Medium riskHealth Canada22 Jun 2026
CA
Recall image placeholder

Penumbra system red 68 reperfusion catheter

Critical riskHealth Canada22 Jun 2026
CA
Recall image placeholder

Med-Rx wound care kit

Medium riskHealth Canada18 Jun 2026
CA
Recall image placeholder

Artis icono ceiling

Medium riskHealth Canada17 Jun 2026
CA
Recall image placeholder

Ge healthcare integrated and stand-alone resuscitation systems

Medium riskHealth Canada16 Jun 2026
CA
Recall image placeholder

Unauthorized soft-shelled hyperbaric chambers may pose serious health risks 2026-06-16

Critical riskHealth Canada16 Jun 2026
CA
Recall image placeholder

Intellicuff®

Medium riskHealth Canada3 Jun 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 1 Jun 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.